tiprankstipranks
Trending News
More News >
Inmune Bio (INMB)
NASDAQ:INMB
US Market

Inmune Bio (INMB) Income Statement

Compare
874 Followers

Inmune Bio Income Statement

Last quarter (Q3 2025), Inmune Bio's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, Inmune Bio's net income was $-6.47M. See Inmune Bio’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 14.00K$ 155.00K$ 374.00K$ 181.00K$ 11.00K
Gross Profit
$ 14.00K$ 155.00K$ 374.00K$ 181.00K$ 11.00K
Operating Expenses
$ 42.65M$ 29.90M$ 26.32M$ 29.33M$ 12.24M
Depreciation and Amortization
$ 553.00K$ 29.74M$ 25.95M$ 29.15M$ 12.23M
EBITDA
$ -42.08M$ 0.00$ 0.00$ 0.00$ 0.00
Operating Income
$ -42.63M$ -29.74M$ -25.95M$ -29.15M$ -12.23M
Other Income/Expenses
$ 553.00K$ -267.00K$ -1.35M$ -1.19M$ 129.00K
Pretax Income
$ -42.08M$ -30.01M$ -27.30M$ -30.34M$ -12.10M
Net Income
$ -42.08M$ -30.01M$ -27.30M$ -30.34M$ -12.10M
Per Share Metrics
Basic EPS
$ -2.11$ -1.67$ -1.52$ -1.88$ -1.01
Diluted EPS
$ -2.11$ -1.67$ -1.52$ -1.88$ -1.01
Weighted Average Shares Outstanding
19.94M 17.98M 17.93M 16.13M 11.99M
Weighted Average Shares Outstanding (Diluted)
19.94M 17.98M 17.93M 16.13M 11.99M
Currency in USD

Inmune Bio Earnings and Revenue History